The number of Americans who say they won't get a COVID shot hasn't budged in a year

COVID vaccine makers shift focus to producing booster shots

With Covid funding stalled, White House prepares for vaccine shortage in the fall

Biden administration decouples new Covid funding requests from Ukraine aid package after runnin g into Republican opposition.

Omicron relatives -- BA.4 and BA.5-- are behind a fresh wave of COVID-19 in South Africa, and could be signs of a more predictable future for SARS-CoV-2.

Florida COVID cases increase by nearly 33,000, highest weekly jump in 2 months

Travel nurses: Covid hospitalizations stabilize and federal and state funding dries up, contracts that were plentiful and lucrative are vanishing

Health experts say the covid situation this summer won't be endemic, yet

U.S. to ask world for more on global Covid fight as its own cash dwindles

The White House is hosting a global Covid response summit this week — but the U.S. isn't currently prepared to bring significant new money to fight the virus worldwide, according to two people familiar with the preparations.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

U.S. coronavirus wave this fall and winter could potentially infect 100 million, White House warns

Analysis of the nearly one million covid deaths in the U.S.--AP

COVID Boosters reduced the Omicron' infections rate in Nursing Homes

An additional booster dose of COVID vaccine helped substantially reduce the rate of infection in nursing home residents during the Omicron wave compared with a primary series alone, researchers found.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Overview: China/Sjanghai, U.S. airlines, other developments

U.S. Prisons prescribed few Paxlovid or other Covid-19 treatments, even when they had supplies

If we don't have the booster campaign early enough we might not be in a great spot in the fall --Moderna CEO

COVID-19: 'We might not be in a great spot in the fall': Moderna CEO

While the U.S. waits on funding and for the U.S. Food and Drug Administration (FDA) to decide on which virus strain to attack through boosters, Moderna and other vaccine companies are anticipating waning immunity to become a concern.

"This virus is not getting less infectious," Moderna CEO Stéphane Bancel told Yahoo Finance. "As you see more and more infectious variants ... We are not done with this virus mutating," he said.

The biggest risk in the fall, if boosting is delayed, is the potential for hospitals to fill up with those that are the most vulnerable all over again, Bancel said.

The increased circulation from the intersection of waning immunity and a more transmissible variant, as is being observed with more Omicron subvariants in the U.S. and abroad, is the real risk, he said.

"We have a risk in the fall — if we don't have the booster campaign early enough —that we might not be in a great spot in the fall," Bancel said.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global RSS
howdy folks